Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy
Tebyan O. Mirgany, A. F. M. Motiur Rahman, Mohammed M. Alanazi
Topics & Concepts
BenzimidazoleHydrazonePharmacologyChemistryCombinatorial chemistryComputational biologyMedicineStereochemistryBiologyOrganic chemistryHER2/EGFR in Cancer ResearchComputational Drug Discovery MethodsCancer therapeutics and mechanisms